UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 28, 2009
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 000-10030
Apple Inc.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
Registrant s telephone number, including area code: (408) 996-1010
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of
Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer,
accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes No
892,109,834 shares of common stock issued and outstanding as of April 13, 2009
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in millions, except share amounts which are reflected in thousands and per share amounts)
Three Months Ended
Six Months Ended
March 28,
2009
March 29,
2008
March 28,
2009
March 29,
2008
Net sales
8,163
7,512
18,330
17,120
Cost of sales
5,192
5,038
11,827
11,314
Gross margin
2,971
2,474
6,503
5,806
Operating expenses:
Research and development
319
273
634
519
Selling, general, and administrative
985
886
2,076
1,846
Total operating expenses
1,304
1,159
2,710
2,365
Operating income
1,667
1,315
3,793
3,441
Other income and expense
63
162
221
362
Income before provision for income taxes
1,730
1,477
4,014
3,803
Provision for income taxes
525
432
1,204
1,177
Net income
1,205
1,045
2,810
2,626
Earnings per common share:
Basic
1.35
1.19
3.16
2.99
Diluted
1.33
1.16
3.11
2.92
Shares used in computing earnings per share:
Basic
891,180
879,546
890,161
877,704
Diluted
902,993
899,329
902,243
899,783
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except share amounts)
March 28,
2009
September 27,
2008
ASSETS:
Current assets:
Cash and cash equivalents
4,466
11,875
Short-term marketable securities
20,547
10,236
Accounts receivable, less allowances of $60 and $47, respectively
1,932
2,422
Inventories
312
509
Deferred tax assets
1,539
1,447
Other current assets
5,057
5,822
Total current assets
33,853
32,311
Long-term marketable securities
3,865
2,379
Property, plant and equipment, net
2,546
2,455
Goodwill
207
207
Acquired intangible assets, net
268
285
Other assets
2,498
1,935
Total assets
43,237
39,572
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
3,976
5,520
Accrued expenses
2,761
3,719
Deferred revenue
7,014
4,853
Total current liabilities
13,751
14,092
Deferred revenue non-current
3,460
3,029
Other non-current liabilities
1,715
1,421
Total liabilities
18,926
18,542
Commitments and contingencies
Shareholders equity:
Common stock, no par value; 1,800,000,000 shares authorized; 891,911,821 and 888,325,973 shares issued and outstanding,
respectively
7,643
7,177
Retained earnings
16,653
13,845
Accumulated other comprehensive income
15
Total shareholders equity
24,311
21,030
Total liabilities and shareholders equity
43,237
39,572
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
Six Months Ended
March 28,
2009
March 29,
2008
Cash and cash equivalents, beginning of the period
11,875
9,352
Operating Activities:
Net income
2,810
2,626
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation, amortization, and accretion
330
222
Stock-based compensation expense
351
242
Deferred income tax (benefit)/expense
(31
Loss on disposition of property, plant, and equipment
10
Changes in operating assets and liabilities:
Accounts receivable, net
490
44
Inventories
197
(18
Other current assets
859
(444
Other assets
(456
(150
Accounts payable
(1,527
(740
Deferred revenue
2,592
1,585
Other liabilities
(844
597
Cash generated by operating activities
4,779
3,980
Investing Activities:
Purchases of marketable securities
(23,483
(12,740
Proceeds from maturities of marketable securities
6,280
6,683
Proceeds from sales of marketable securities
5,457
1,676
Purchases of other long-term investments
(54
(17
Payment for acquisition of property, plant, and equipment
(439
(384
Payment for acquisition of intangible assets
(30
(63
Other
(55
21
Cash used in investing activities
(12,324
(4,824
Financing Activities:
Proceeds from issuance of common stock
122
233
Excess tax benefits from stock-based compensation
47
445
Cash used to net share settle equity awards
(33
(116
Cash generated by financing activities
136
562
Decrease in cash and cash equivalents
(7,409
(282
Cash and cash equivalents, end of the period
4,466
9,070
Supplemental cash flow disclosure:
Cash paid for income taxes, net
1,828
753
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting
Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) design, manufacture,
and market personal computers, portable digital music players, and mobile communication devices and sell a variety of related software, third-party digital content and applications, services, peripherals, and networking solutions. The Company sells
its products worldwide through its online stores, its retail stores, its direct sales force, and third-party wholesalers, resellers, and value-added resellers. In addition, the Company sells a variety of third-party Mac, iPod, and iPhone compatible
products including application software, printers, storage devices, speakers, headphones, and various other accessories and supplies through its online and retail stores. The Company sells to consumer, small and mid-sized business ( SMB ),
education, enterprise, government, and creative markets.
Basis of Presentation and Preparation
The accompanying Condensed Consolidated Financial Statements include the accounts of the Company. Intercompany accounts and transactions have been
eliminated. The accompanying Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary to present fairly the Condensed Consolidated Financial
Statements for all periods presented. The preparation of these Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts
reported in these Condensed Consolidated Financial Statements and accompanying notes. Actual results could differ materially from those estimates.
Certain prior year amounts in the Condensed Consolidated Financial Statements and notes thereto have been reclassified to conform to the current period s presentation. During the first quarter of 2009, the Company reclassified
$2.4 billion of certain fixed-income securities from short-term marketable securities to long-term marketable securities in the September 27, 2008 Condensed Consolidated Balance Sheet. The reclassification resulted from a change in
accounting presentation for certain investments based on contractual maturity dates, which more closely reflects the Company s assessment of the timing of when such securities will be converted to cash. As a result of this change, marketable
securities with maturities less than 12 months are classified as short-term and marketable securities with maturities greater than 12 months are classified as long-term. There have been no changes in the Company s investment policies or
practices associated with this change in accounting presentation. See Note 2, Financial Instruments of this Form 10-Q for additional information.
These Condensed Consolidated Financial Statements and accompanying notes should be read in conjunction with the Company s annual Consolidated Financial Statements and the notes thereto for the fiscal year ended
September 27, 2008, included in its Annual Report on Form 10-K (the 2008 Form 10-K ). Unless otherwise stated, references to particular years or quarters refer to the Company s fiscal years ended in September and the associated
quarters of those fiscal years.
Earnings Per Common Share
Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per common share
is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been
outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding options, shares to be purchased under the employee stock purchase plan, and unvested restricted stock units ( RSUs ).
The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company s common stock
can result in a greater dilutive effect from potentially dilutive securities.
The following table sets forth the computation of basic and diluted earnings per share for the three- and
six-month periods ended March 28, 2009 and March 29, 2008 (in thousands, except net income in millions and per share amounts):
Three Months Ended
Six Months Ended
March 28,
2009
March 29,
2008
March 28,
2009
March 29,
2008
Numerator:
Net income
1,205
1,045
2,810
2,626
Denominator:
Weighted-average shares outstanding
891,180
879,546
890,161
877,704
Effect of dilutive securities
11,813
19,783
12,082
22,079
Denominator for diluted earnings per share
902,993
899,329
902,243
899,783
Basic earnings per share
1.35
1.19
3.16
2.99
Diluted earnings per share
1.33
1.16
3.11
2.92
Potentially dilutive securities representing approximately 19.2 million and 12.3 million
shares of common stock for the three months ended March 28, 2009 and March 29, 2008, respectively, and 18.0 million and 8.6 million shares of common stock for the six months ended March 28, 2009 and March 29, 2008,
respectively, were excluded from the computation of diluted earnings per share for these periods because their effect would have been antidilutive.
Fair Value Measurements
During the first quarter of 2009, the Company adopted Financial Accounting Standards Board
( FASB ) Statement of Financial Accounting Standards ( SFAS ) No. 157, Fair Value Measurements, which defines fair value, establishes guidelines for measuring fair value and expands disclosures regarding fair value
measurements. SFAS No. 157 does not require any new fair value measurements, but rather eliminates inconsistencies in guidance found in various other accounting pronouncements. The adoption of SFAS No. 157 did not have a material effect on
the Company s financial condition or operating results.
SFAS No. 157 establishes a hierarchy for information and valuations used
in measuring fair value, which is broken down into three levels. Level 1 valuations are based on quoted prices in active markets for identical assets or liabilities. Level 2 valuations are based on inputs that are observable, either directly or
indirectly, other than quoted prices included within Level 1. Level 3 valuations are based on information that is unobservable and significant to the overall fair value measurement.
The Company also adopted SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities including an amendment of FASB Statement No. 115, during the
first quarter of 2009. SFAS No. 159 allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. SFAS No. 159 requires that unrealized
gains and losses on items for which the fair value option has been elected be reported in earnings at each reporting date. The Company adopted SFAS No. 159 but has not elected the fair value option for any eligible financial instruments.
Refer to Note 3, Fair Value Measurements of this Form 10-Q for additional information on the adoption of SFAS Nos. 157 and
159.
Derivative Financial Instruments
During the second quarter of 2009, the Company adopted SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities an amendment of FASB Statement No. 133, which requires additional disclosures about
the Company s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities,
and related interpretations, and how the derivative instruments and related hedged items affect the financial statements. The adoption of SFAS No. 161 had no financial impact on the Company s Condensed Consolidated Financial Statements.
Refer to Note 2, Financial Instruments of this Form 10-Q for additional information on the adoption of SFAS No. 161.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following table summarizes the fair value of
the Company s cash and available-for-sale securities held in its marketable securities investment portfolio, recorded as cash, cash equivalents, short-term or long-term marketable securities as of March 28, 2009 and September 27, 2008
(in millions):
March 28, 2009
September 27, 2008
Cash
622
368
Money market funds
1,808
1,536
U.S. Treasury securities
340
118
U.S. agency securities
777
2,798
Certificates of deposit and time deposits
610
2,560
Commercial paper
309
4,429
Corporate securities
66
Total cash equivalents
3,844
11,507
U.S. Treasury securities
1,116
343
U.S. agency securities
15,632
5,823
Non-U.S. government securities
54
83
Certificates of deposit and time deposits
196
486
Commercial paper
1,295
1,254
Corporate securities
2,249
2,247
Municipal securities
Total short-term marketable securities
20,547
10,236
U.S. Treasury securities
195
100
U.S. agency securities
1,375
751
Certificates of deposit and time deposits
32
Corporate securities
2,232
1,496
Municipal securities
63
Total long-term marketable securities
3,865
2,379
Total cash, cash equivalents and marketable securities
28,878
24,490
As of December 27, 2008, the Company changed its accounting presentation for certain
fixed-income investments, which resulted in the reclassification of certain investments from short-term marketable securities to long-term marketable securities. As a result, prior period balances have been reclassified to conform to the current
period s presentation. The Company classifies its marketable securities as either short-term or long-term based on each instrument s underlying contractual maturity date, while its prior classifications were based on the nature of the
securities and their availability for use in current operations. As a result of this change, marketable securities with maturities of less than 12 months are classified as short-term and marketable securities with maturities greater than 12 months
are classified as long-term. The Company s long-term marketable securities maturities range from one year to five years. The Company believes this new presentation is preferable as it more closely reflects the Company s assessment of
the timing of when such securities will be converted to cash. Accordingly, certain fixed-income investments totaling $2.4 billion have been reclassified from short-term marketable securities to long-term marketable securities in the
September 27, 2008 Condensed Consolidated Balance Sheet to conform to the current period s financial statement presentation. There have been no changes in the Company s investment policies or practices associated with this change in
accounting presentation.
The Company had net unrealized losses on its investment portfolio of $69 million and $117 million as of
March 28, 2009 and September 27, 2008, respectively. In both periods, the net unrealized losses related primarily to long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated
maturities for strategic purposes, in anticipation of credit deterioration, or for duration management. The Company recognized no material net gains or losses during the three- and six-month periods ended March 28, 2009 and March 29, 2008
related to such sales.
The following table shows the gross unrealized losses and fair value for investments in an unrealized loss position
as of March 28, 2009 and September 27, 2008, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
March 28, 2009
Less than 12 Months
12 Months or Greater
Total
Security Description
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
U.S. agency securities
2,375
(2
2,375
(2
Corporate securities
1,422
(16
1,109
(106
2,531
(122
Total
3,797
(18
1,109
(106
4,906
(124
September 27, 2008
Less than 12 Months
12 Months or Greater
Total
Security Description
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
U.S. agency securities
6,822
(13
6,822
(13
Corporate securities
2,147
(31
1,148
(77
3,295
(108
Total
8,969
(44
1,148
(77
10,117
(121
The Company considers the declines in market value of its marketable securities investment
portfolio to be temporary in nature. The unrealized losses on the Company s marketable securities were caused primarily by changes in market interest rates, specifically, widening credit spreads. The Company typically invests in highly-rated
securities, and its policy generally limits the amount of credit exposure to any one issuer. The Company s investment policy requires investments to be rated single-A or better, with the objective of minimizing the potential risk of principal
loss. Fair values were determined for each individual security in the investment portfolio. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value
has been below cost basis, the financial condition of the issuer, and the Company s ability and intent to hold the investment for a period of time, which may be sufficient for anticipated recovery in market value. During the three- and
six-month periods ended March 28, 2009 and March 29, 2008, the Company did not recognize any material impairment charges on outstanding securities. As of March 28, 2009, the Company does not consider any of its investments to be
other-than-temporarily impaired.
Derivative Financial Instruments
The Company uses derivatives to partially offset its business exposure to foreign exchange risk. The Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk of
expected future cash flows on certain forecasted revenue and cost of sales, of net investments in certain foreign subsidiaries, and on certain existing assets and liabilities. To help protect gross margins from fluctuations in foreign currency
exchange rates, certain of the Company s subsidiaries whose functional currency is the U.S. dollar, hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who
sell in local currencies, may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with
revenue and inventory purchases for three to six months. To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to
offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. The Company may also enter into foreign currency forward and option contracts to partially offset the foreign exchange gains and
losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge
certain foreign exchange exposures for a variety of reasons, including but not limited to immateriality, accounting considerations, and the prohibitive
economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange rates. As of the end of the second quarter of 2009, the general
nature of the Company s risk management activities and the general nature and mix of the Company s derivative financial instruments have not changed materially from the end of 2008.
The Company s accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments in accordance with SFAS No. 133. The
Company records all derivatives on the balance sheet at fair value. The effective portions of cash flow hedges are recorded in other comprehensive income until the hedged item is recognized in earnings. The effective portions of net investment
hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. Derivatives that are not designated as hedging instruments and the ineffective portions of cash flow hedges and net investment hedges are adjusted
to fair value through earnings in other income and expense.
The Company had a net deferred gain associated with cash flow hedges of
approximately $72 million and $19 million, net of taxes, recorded in other comprehensive income as of March 28, 2009 and September 27, 2008, respectively. Other comprehensive income associated with cash flow hedges of foreign currency
revenue is recognized as a component of net sales in the same period as the related revenue is recognized, and other comprehensive income related to cash flow hedges of inventory purchases is recognized as a component of cost of sales in the same
period as the related costs are recognized. The portion of the Company s net deferred gain related to products under subscription accounting is expected to be recorded in earnings ratably over the related products estimated economic lives
beginning when the hedged transactions occur, while the portion of the net deferred gain related to other products is expected to be recorded in earnings at the time the hedged transactions occur. As of March 28, 2009, the hedged transactions
are expected to occur within six months.
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is
probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two month time period. Deferred gains and losses in other comprehensive income associated with such derivative instruments are
reclassified immediately into earnings through other income and expense. Any subsequent changes in fair value of such derivative instruments also are reflected in current earnings unless they are re-designated as hedges of other transactions. The
Company did not recognize any material net gains related to the loss of hedge designation on discontinued cash flow hedges during the three- and six-month periods ended March 28, 2009 and March 29, 2008, respectively.
The Company had an unrealized net gain on net investment hedges of $6 million, net of tax, and an unrealized net loss on net investment hedges of $1
million, net of tax, included in the cumulative translation adjustment account of accumulated other comprehensive income ( AOCI ) as of March 28, 2009 and September 27, 2008, respectively. The ineffective portions and amounts
excluded from the effectiveness test of net investment hedges are recorded in current earnings in other income and expense.
The Company
recognized in earnings a total net gain on foreign currency forward and option contracts not designated as hedging instruments in accordance with SFAS No. 133 of $15 million and $173 million during the three- and six-month periods ended
March 28, 2009, respectively.
The following table shows the notional principal and credit risk amounts of the Company s derivative
instruments as of March 28, 2009 (in millions):
March 28, 2009
Notional
Principal
Credit Risk
Amounts
Instruments qualifying as accounting hedges:
Foreign exchange contracts
2,981
75
Instruments other than accounting hedges:
Foreign exchange contracts
2,351
29
The notional principal amounts for derivative instruments provide one measure of the transaction
volume outstanding as of March 28, 2009, and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts shown in the table above represent the Company s gross exposure to potential
accounting loss on these transactions if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates. The Company s exposure to credit loss and market risk will vary over time as a
function of currency exchange rates. Although the table above reflects the notional principal and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and
transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market
conditions during the remaining life of the instruments.
The estimates of fair value are based on applicable and commonly used pricing
models and prevailing financial market information as of March 28, 2009. Refer to Note 3, Fair Value Measurements of this Form 10-Q, for additional information on the fair value measurements for all financial assets and liabilities,
including derivative assets and derivative liabilities, that are measured at fair value in the Condensed Consolidated Financial Statements on a recurring basis. The following table shows the Company s derivative instruments measured at gross
fair value as reflected in the Condensed Consolidated Balance Sheet as of March 28, 2009 (in millions):
March 28, 2009
Fair Value of
Derivatives Designated
as Hedge Instruments
Fair Value of Derivatives
Not Designated as Hedge
Instruments
Derivative assets (a):
Foreign exchange contracts
70
30
Derivative Liabilities (b):
Foreign exchange contracts
34
16
(a)
All derivative assets are recorded as other current assets in the Condensed Consolidated Balance Sheet.
(b)
All derivative liabilities are recorded as accrued expenses in the Condensed Consolidated Balance Sheet.
10
The following tables show the effect of the Company s derivative instruments designated as cash flow
and net investment hedges in the Condensed Consolidated Statement of Operations for the three- and six-month periods ended March 28, 2009 (in millions):
Three Months Ended March 28, 2009
Gain or (Loss)
Recognized in
AOCI -
Effective
Portion (a)
Location of
Gain or (Loss)
Reclassified
from AOCI into
Income -
Effective
Portion
Gain or (Loss)
Reclassified
from AOCI
into Income -
Effective
Portion (a)
Location of Gain
or (Loss)
Recognized
Ineffective
Portion and
Amount Excluded
from
Effectiveness
Testing
Gain or (Loss)
Recognized -
Ineffective Portion
and Amount
Excluded from
Effectiveness
Testing
Cash flow hedges:
Foreign exchange contracts
27
Net sales
79
Other income and expense
(28
Foreign exchange contracts
27
Cost of sales
25
Other income and expense
(6
Net investment hedges:
Foreign exchange contracts
16
Other income and expense
Other income and expense
Total
70
104
(34
Six Months Ended March 28, 2009
Gain or (Loss)
Recognized in
AOCI -
Effective
Portion (a)
Location of
Gain or (Loss)
Reclassified
from AOCI into
Income -
Effective
Portion
Gain or (Loss)
Reclassified
from AOCI
into Income -
Effective
Portion (a)
Location of Gain
or (Loss)
Recognized
Ineffective
Portion and
Amount Excluded
from
Effectiveness
Testing
Gain or (Loss)
Recognized -
Ineffective Portion
and Amount
Excluded from
Effectiveness
Testing
Cash flow hedges:
Foreign exchange contracts
298
Net sales
240
Other income and expense
(51
Foreign exchange contracts
123
Cost of sales
97
Other income and expense
(5
Net investment hedges:
Foreign exchange contracts
(22
Other income and expense
Other income and expense
Total
399
337
(54
(a)
Refer to Note 6, Shareholders Equity of this Form 10-Q, which summarizes the activity in other comprehensive income related to derivatives.
Note 3 Fair Value Measurements
In the first quarter of 2009, the Company adopted SFAS No. 157 for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial
statements on a recurring basis. SFAS No. 157 defines fair value as the price that would be received from selling an asset or paid to transfer a
11
liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and
liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would
use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk.
SFAS No. 157 also establishes a
fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three levels. A financial instrument s categorization within the fair value hierarchy is based upon the lowest level of input that is
available and significant to the fair value measurement. SFAS No. 157 establishes and prioritizes three levels of inputs that may be used to measure fair value:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 -
Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by
observable market data for substantially the full term of the assets or liabilities.
Level 3 - Inputs that are generally
unobservable and typically reflect management s estimates of assumptions that market participants would use in pricing the asset or liability.
Assets/Liabilities Measured at Fair Value on a Recurring Basis
The following table presents the Company s assets and
liabilities measured at fair value on a recurring basis as of March 28, 2009 (in millions):